Morgan Stanley Maintains Equal-Weight on Adaptive Biotechnologies, Lowers Price Target to $18
Adaptive Biotechnologies Corp ADPT
$13.96
▲ +7.72%
(+$1.00)
Open
$13.05
Prev Close
$12.96
Day Range
$12.92 – $13.99
52W Range
$8.50 – $20.76
Market Cap
$2.10B
Beta
2.16
EPS (TTM)
$-0.33
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-06-27 |
| Shares Out. | 160,040,000 |
| Website | adaptivebiotech.com ↗ |
| Phone | 12066590067 |
Adaptive Biotechnologies Corp is a publicly traded company under the ticker symbol ADPT on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-05-01)
📰 Latest News for ADPT
Adaptive Biotechnologies Corporation 2026 Q1 - Results - Earnings Call Presentation
JP Morgan Maintains Overweight on Adaptive Biotechnologies, Lowers Price Target to $19
TD Cowen Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $21
Guggenheim Reiterates Buy on Adaptive Biotechnologies, Maintains $21 Price Target
BTIG Reiterates Buy on Adaptive Biotechnologies, Maintains $22 Price Target